GEP-NET

Clinical trials for GEP-NET explained in plain language.

Never miss a new study

Get alerted when new GEP-NET trials appear

Sign up with your email to follow new studies for GEP-NET, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Terminated 1

Trial for 3-month hormone shot ends early

Disease control Terminated

This early-stage study tested a new, longer-acting version of a common hormone-controlling drug (octreotide). It aimed to see how the body processes the drug and if it's safe for people with acromegaly or certain gut/pancreatic tumors (GEP-NETs). The trial involved 19 participant…

Matched conditions: GEP-NET

Phase: PHASE1 • Sponsor: Debiopharm International SA • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

GEP-NET

Get alerted when new GEP-NET trials appear

Trial for 3-month hormone shot ends early